XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 20.88%110.5B | 12.56%100.61B | 2.84%89.15B | -7.83%353.89B | -15.27%86.41B | -7.60%91.41B | -3.05%89.38B | -4.60%86.68B | 5.92%383.97B | -6.43%101.98B |
Operating revenue | 20.39%113.96B | 12.62%103.98B | 3.02%92.36B | -7.83%353.89B | -17.20%77.25B | -7.00%94.66B | -3.01%92.32B | -4.32%89.65B | 5.92%383.97B | -8.05%93.3B |
Excise taxes | -0.99%1.02B | 17.80%1.05B | 22.73%1.07B | ---- | ---- | 17.16%1.03B | 2.21%891.72M | 4.77%873.31M | ---- | ---- |
Cost of revenue | 14.87%92.31B | 7.04%85.09B | -2.03%77.47B | -2.39%315.22B | -14.97%76.3B | -2.82%80.36B | 4.59%79.5B | 6.13%79.07B | 9.84%322.93B | 2.71%89.73B |
Gross profit | 64.56%18.19B | 56.89%15.51B | 53.41%11.68B | -36.66%38.67B | -17.46%10.11B | -31.93%11.05B | -38.92%9.89B | -53.47%7.61B | -10.87%61.04B | -43.35%12.25B |
Operating expense | 13.77%9.55B | 11.53%9.19B | -1.98%8.09B | -9.11%32.76B | -19.63%7.95B | -7.11%8.39B | 0.07%8.24B | -6.71%8.25B | 16.48%36.04B | 34.32%9.89B |
Selling and administrative expenses | 13.30%9.09B | 12.33%8.74B | -4.60%7.77B | -9.40%31.66B | -18.68%7.79B | -10.34%8.02B | -1.64%7.78B | -3.88%8.14B | 17.38%34.95B | 41.52%9.58B |
-Selling and marketing expense | 3.40%5.22B | 2.28%5.31B | -6.67%5B | -11.46%20.48B | -24.55%4.88B | -14.76%5.05B | -2.26%5.2B | -0.52%5.36B | 25.59%23.13B | 4.65%6.46B |
-General and administrative expense | 30.12%3.87B | 32.54%3.42B | -0.60%2.77B | -5.38%11.18B | -6.51%2.92B | -1.68%2.97B | -0.37%2.58B | -9.74%2.78B | 4.07%11.82B | 424.63%3.12B |
Depreciation amortization depletion | 0.34%348.05M | 1.69%314.24M | -5.51%315.02M | -2.32%1.34B | -5.92%345.74M | 4.72%346.87M | -3.42%309.03M | -4.21%333.4M | 7.64%1.37B | -3.18%367.51M |
-Depreciation and amortization | 0.34%348.05M | 1.69%314.24M | -5.51%315.02M | -2.32%1.34B | -5.92%345.74M | 4.72%346.87M | -3.42%309.03M | -4.21%333.4M | 7.64%1.37B | -3.18%367.51M |
Other taxes | ---- | ---- | ---- | 13.04%-236.96M | ---- | ---- | ---- | ---- | -171.15%-272.49M | ---- |
Other operating expenses | 349.38%113.31M | -8.83%140.98M | 102.89%6.45M | ---- | ---- | 110.42%25.22M | 1,912.66%154.63M | -915.75%-222.76M | ---- | ---- |
Operating profit | 224.92%8.64B | 283.93%6.32B | 663.91%3.59B | -76.38%5.91B | -8.39%2.17B | -63.07%2.66B | -79.30%1.65B | -108.47%-637.11M | -33.42%25B | -83.42%2.36B |
Net non-operating interest income expense | -7.86%-1.93B | -1.58%-1.79B | 1.23%-1.74B | -4.37%-7.25B | -7.28%-1.95B | -18.06%-1.78B | 10.56%-1.76B | -6.42%-1.76B | -26.59%-6.95B | 1.51%-1.82B |
Non-operating interest income | 44.60%547.15M | 59.34%628.11M | 27.37%447.44M | 11.62%1.58B | 22.33%460.43M | -19.03%378.39M | 25.89%394.19M | 33.82%351.28M | 76.46%1.42B | 44.57%376.39M |
Non-operating interest expense | 5.84%2.21B | 7.71%2.25B | 1.28%2.08B | 18.47%8.41B | 4.50%2.17B | 20.96%2.09B | 22.40%2.09B | 29.89%2.05B | 30.62%7.1B | 21.08%2.08B |
Total other finance cost | 264.99%257.41M | 162.55%162.14M | 85.68%104.8M | -66.54%424.03M | 109.00%235.31M | -71.69%70.52M | -89.19%61.76M | -83.11%56.44M | 47.86%1.27B | -70.86%112.59M |
Other net income (expense) | 9.98%-74.37M | -11,701.44%-1.73B | -114.46%-35.57M | -88.63%84.03M | -97.91%6.48M | 53.17%-82.62M | 98.12%-14.68M | -81.69%246M | 119.23%739.13M | 108.26%309.83M |
Gain on sale of security | -42.35%-77.22M | -1,558.97%-1.34B | -95.64%8.88M | 79.05%681.65M | 182.78%440.32M | -447.99%-54.25M | 116.87%91.89M | -85.87%203.68M | 48.11%380.71M | -1,456.98%-531.9M |
Earnings from equity interest | 9.92%21.61M | -16.44%12.54M | -324.39%-32.35M | -25.82%46.28M | -124.22%-2.8M | 32.84%19.66M | -28.07%15.01M | -4.90%14.42M | -34.83%62.4M | -52.30%11.57M |
Special income (charges) | 60.93%-18.76M | -232.10%-403.74M | -143.34%-12.09M | -35.03%-750.06M | -2,417.42%-537.19M | 76.78%-48.03M | 52.42%-121.57M | 124.69%27.9M | 87.59%-555.48M | 99.48%-21.34M |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | 33.57%215.18M | ---- | ---- | ---- | ---- | --161.1M | ---- |
-Less:Other special charges | -92.42%3.88M | 342.45%394.33M | ---- | -9.12%409.75M | 586.18%198.21M | -68.81%51.25M | -62.64%89.13M | ---- | -89.79%450.86M | ---40.77M |
-Write off | 563.04%14.88M | -70.99%9.41M | 143.34%12.09M | 187.09%37.6M | 223.32%36.27M | -107.56%-3.21M | 91.45%32.45M | -214.95%-27.9M | -77.13%13.1M | 90.86%-29.41M |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | -225.80%-87.53M | ---- | ---- | ---- | ---- | 42,948.92%69.58M | ---- |
Other non- operating income (expenses) | ---- | ---- | ---- | -87.53%106.16M | ---- | ---- | ---- | ---- | 205.10%851.51M | ---- |
Income before tax | 739.22%6.64B | 2,287.03%2.8B | 184.74%1.82B | -106.71%-1.26B | -73.77%225.43M | -85.65%791.04M | -102.46%-128.09M | -129.79%-2.15B | -33.41%18.79B | -90.09%859.29M |
Income tax | 2,332.40%2.44B | 1,010.70%778.34M | 101.92%13.84M | -128.66%-621.18M | 95.93%-72.3M | -91.95%100.43M | -92.40%70.08M | -140.54%-719.38M | -68.74%2.17B | -226.81%-1.78B |
Net income | 507.54%4.2B | 1,120.88%2.02B | 226.42%1.81B | -103.85%-639.34M | -88.70%297.73M | -83.80%690.61M | -104.63%-198.17M | -126.28%-1.43B | -21.89%16.62B | -63.74%2.64B |
Net income continuous Operations | 507.54%4.2B | 1,120.88%2.02B | 226.42%1.81B | -103.85%-639.34M | -88.70%297.73M | -83.80%690.61M | -104.63%-198.17M | -126.28%-1.43B | -21.89%16.62B | -63.74%2.64B |
Minority interest income | 199.38%353.14M | 370.29%307.84M | 597.42%161.12M | -57.81%325.81M | 212.12%119.3M | -52.88%117.96M | -80.27%65.46M | -92.21%23.1M | 1,825.65%772.28M | -365.92%-106.41M |
Net income attributable to the parent company | 571.01%3.84B | 750.63%1.72B | 213.31%1.65B | -106.09%-965.15M | -93.49%178.42M | -85.73%572.65M | -106.67%-263.62M | -128.25%-1.45B | -25.38%15.85B | -62.07%2.74B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 571.01%3.84B | 750.63%1.72B | 213.31%1.65B | -106.09%-965.15M | -93.49%178.42M | -85.73%572.65M | -106.67%-263.62M | -128.25%-1.45B | -25.38%15.85B | -62.07%2.74B |
Basic earnings per share | 565.38%3.46 | 741.67%1.54 | 213.85%1.48 | -106.16%-0.8736 | -93.15%0.1664 | -85.64%0.52 | -106.74%-0.24 | -128.38%-1.3 | -17.44%14.1713 | -58.12%2.4313 |
Diluted earnings per share | 565.38%3.46 | 741.67%1.54 | 213.85%1.48 | -106.16%-0.8736 | -93.15%0.1664 | -85.64%0.52 | -106.74%-0.24 | -128.38%-1.3 | -17.44%14.1713 | -58.12%2.4313 |
Dividend per share | 4.1172 | 0 | 0 | -49.46%1.9942 | 0 | 0 | 0.84%1.9942 | 0 | -33.56%3.9461 | -1.42%1.9686 |
Currency Unit | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |